Michael Orr, MD
Ophthalmology · Indianapolis, INNPI 1144264136
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Lensar, Inc. accounts for 86.2% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $15,770 and has fallen 97.4% since, to $415 in 2025. Among ophthalmology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 131 payments — averaging $197.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lensar, Inc.$22K
- Glaukos Corporation$1K
- AbbVie$637
- Alcon$296
- Rxsight Inc$289
- Novartis$171
- plus $750 from 16 others
What the payments were for
- Consulting fees$13,23451%
- Speaking & faculty fees$6,56625%
- Food & beverage$6,06923%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lensar, Inc. | 38 | $22,305 |
| Glaukos Corporation | 15 | $1,421 |
| AbbVie(2 entities) | 13 | $637 |
| Alcon | 14 | $296 |
| Rxsight Inc | 8 | $289 |
| Novartis | 9 | $171 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $157 |
| Bausch & Lomb Americas Inc. | 7 | $141 |
| Mallinckrodt Hospital Products Inc. | 3 | $88 |
| Dompe US, Inc. | 2 | $64 |
| Ocular Therapeutix, Inc. | 4 | $58 |
| Biotissue Holdings Inc. | 2 | $46 |
| Notal Vision, Inc. | 1 | $31 |
| Tarsus Pharmaceuticals, Inc. | 1 | $25 |
| Harrow Eye, LLC | 1 | $23 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Sight Sciences, Inc. | 1 | $21 |
| Shire North American Group Inc | 1 | $20 |
| Carl Zeiss Meditec USA, Inc. | 1 | $19 |
| Z-medica, LLC | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| NEW World Medical,inc. | 2 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENSAR LASER SYSTEM$21,836
- iStent infinite Trabecular Micro-Bypass System Model iS3$345
- iStent Trabecular Micro-Bypass System Model iS3$340
- RADIUS$306
- iS3-iStent infiniteTrabecular Micro-Bypass System Model iS3$173
- LUMIGAN$150
- iDose$146
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$116
- Tecnis Simplicity$111
- DURYSTA$108
How this compares
$25,869 in reported general payments places this provider in the 95th percentile of 266 ophthalmology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 33 | $1,535 |
| Ketorolac Tromethamine | 25 | $980 |
| Ofloxacin | 25 | $481 |
| Latanoprost | 14 | $152 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Indianapolis
- Kevin WaltzIndianapolis$199K
- Janet HummerIndianapolis$96K
- Francis PriceIndianapolis$67K
- Matthew FengIndianapolis$22K
- John LindIndianapolis$20K
- Shaohui LiuIndianapolis$19K
- John LatonaIndianapolis$18K
- William WhitsonIndianapolis$15K
- Thierry WilbrandtIndianapolis$13K
- Anthony LombardoIndianapolis$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.